April 27, 2012

Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio Vaccine

- Approval of IMOVAX® POLIO by Japanese health authorities, a major milestone towards a polio-free world -

 

Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio Vaccine
- Approval of IMOVAX® POLIO by Japanese health authorities, a major milestone towards a polio-free world -

Lyon, France and Tokyo, Japan – April 27, 2012 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company’s standalone Inactivated Poliovirus Vaccine (IPV) against acute flaccid poliomyelitis (IMOVAX® POLIO). IMOVAX® POLIO will be added to the country’s public immunization program on September 1st.